{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:55:29Z","timestamp":1789685729934,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.arbres.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T23:16:04Z","timestamp":1494285364000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Gu\u00eda espa\u00f1ola de la EPOC (GesEPOC) y la Gu\u00eda Espa\u00f1ola para el Manejo del Asma (GEMA)"],"prefix":"10.1016","volume":"53","author":[{"given":"Vicente","family":"Plaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja G.","family":"Cos\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antol\u00edn","family":"L\u00f3pez-Vi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"P\u00e9rez de Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rom\u00e1n-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2017.04.002_bib0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arbres.2012.04.001","article-title":"Spanish COPD guidelines (GesEPOC) Pharmacological treatment of stable COPD","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2017.04.002_bib0235","doi-asserted-by":"crossref","first-page":"1601970","DOI":"10.1183\/13993003.01970-2016","article-title":"A new alphabet for COPD care: Where E stands for Espa\u00f1a","volume":"49","author":"Young","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2017.04.002_bib0240","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/COPD.S88667","article-title":"What pulmonologists think about the asthma-COPD overlap syndrome ACOS","volume":"10","author":"Miravitlles","year":"2015","journal-title":"Int J Chron Obst Pulm Dis"},{"issue":"Suppl 1","key":"10.1016\/j.arbres.2017.04.002_bib0245","first-page":"2","article-title":"Gu\u00eda Espa\u00f1ola para el Manejo del Asma","volume":"51","author":"GEMA4.0.","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2017.04.002_bib0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arbres.2015.07.005","article-title":"Mixed COPD-asthma phenotype: ACOS or CAOS? A reflection on recent guidelines and recommendations","volume":"52","author":"Fern\u00e1ndez-Villar","year":"2016","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2017.04.002_bib0255","series-title":"The Delphi Method: An experimental study of group opinion","author":"Dalkey","year":"1969"},{"key":"10.1016\/j.arbres.2017.04.002_bib0260","series-title":"The Delphi Method III: Use of self ratings to improve group estimates","author":"Dalkey","year":"1969"},{"key":"10.1016\/j.arbres.2017.04.002_bib0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1164\/rccm.201205-0788OC","article-title":"The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age","volume":"187","author":"Perret","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2017.04.002_bib0270","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care"},{"key":"10.1016\/j.arbres.2017.04.002_bib0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MCP.0000000000000118","article-title":"The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges","volume":"21","author":"Barrecheguren","year":"2015","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1378\/chest.13-0622","article-title":"Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype COPD asthma","volume":"145","author":"Menezes","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2017.04.002_bib0285","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.rmed.2013.03.007","article-title":"Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status","volume":"107","author":"Miravitlles","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2017.04.002_bib0290","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like Features and Clinical Course of COPD: An analysis from the Hokkaido COPD Cohort Study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2015.10.004","article-title":"Understanding asthma-chronic obstructive pulmonary disease overlap syndrome","volume":"110","author":"Wurst","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2017.04.002_bib0300","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.15-1055","article-title":"Defining the asthma-COPD overlap syndrome in a COPD cohort","volume":"149","author":"Cosio","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2017.04.002_bib0305","doi-asserted-by":"crossref","first-page":"e62985","DOI":"10.1371\/journal.pone.0062985","article-title":"The coexistence of asthma and chronic obstructive pulmonary disease (COPD): Prevalence and risk factors in young, middle-aged and elderly people from the general population","volume":"10","author":"De Marco","year":"2013","journal-title":"PloSOne"},{"key":"10.1016\/j.arbres.2017.04.002_bib0310","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/02770903.2011.555576","article-title":"Overlap syndrome of asthma and COPD predicts low quality of life","volume":"48","author":"Kauppi","year":"2011","journal-title":"J Asthma"},{"key":"10.1016\/j.arbres.2017.04.002_bib0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.07-2317","article-title":"Burden of concomitant asthma and COPD in a Medicaid population","volume":"134","author":"Shaya","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2017.04.002_bib0320","doi-asserted-by":"crossref","first-page":"e0136065","DOI":"10.1371\/journal.pone.0136065","article-title":"Asthma and COPD Overlap Syndrome (ACOS): A systematic review and meta analysis","volume":"10","author":"Alshabanat","year":"2015","journal-title":"PloSOne"},{"key":"10.1016\/j.arbres.2017.04.002_bib0325","first-page":"1443","article-title":"Clinical characteristics of the asthma-COPD overlap syndrome\u2014a systematic review","volume":"10","author":"Nielsen","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2017.04.002_bib0330","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2013.01.001","article-title":"Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD)","volume":"107","author":"Izquierdo-Alonso","year":"2013","journal-title":"Respir Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0335","doi-asserted-by":"crossref","first-page":"e0160770","DOI":"10.1371\/journal.pone.0160770","article-title":"Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort","volume":"11","author":"Cosio","year":"2016","journal-title":"PLoSOne"},{"key":"10.1016\/j.arbres.2017.04.002_bib0340","doi-asserted-by":"crossref","first-page":"992","DOI":"10.5588\/ijtld.15.0021","article-title":"Frequency and characteristics of different clinical phenotypes of COPD","volume":"19","author":"Miravitlles","year":"2015","journal-title":"Int J Tub Lung Dis"},{"key":"10.1016\/j.arbres.2017.04.002_bib0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1465-9921-12-127","article-title":"The clinical features of the overlap between COPD and asthma","volume":"12","author":"Hardin","year":"2011","journal-title":"Respir Res."},{"key":"10.1016\/j.arbres.2017.04.002_bib0350","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.chest.2015.12.002","article-title":"Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life","volume":"149","author":"Van Boven","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2017.04.002_bib0355","doi-asserted-by":"crossref","first-page":"1700048","DOI":"10.1183\/13993003.00068-2017","article-title":"Algorithm for identification of ACO: Consensus between the Spanish COPD and asthma guidelines","volume":"49","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2017.04.002_bib0360","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2017.04.002_bib0365","first-page":"23","article-title":"Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients","volume":"11","author":"Park","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2017.04.002_bib0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting \u03b2-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2017.04.002_bib0375","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0380","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0385","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0390","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08923973.2016.1173057","article-title":"Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"10.1016\/j.arbres.2017.04.002_bib0395","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chest.2016.09.035","article-title":"Omalizumab treatment response in a severe allergic asthma population with overlapping COPD","volume":"151","author":"Maltby","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2017.04.002_bib0400","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/13993003.00436-2016","article-title":"What is asthma-COPD overlap syndrome (ACOS)? Towards a consensus definition from a round table discussion","volume":"48","author":"Sin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2017.04.002_bib0405","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1513\/AnnalsATS.201511-761OC","article-title":"Analysis of asthma-chronic obstructive pulmonary disease overlap syndrome defined on the basis of bronchodilator response and degree of emphysema","volume":"13","author":"Cosentino","year":"2016","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.arbres.2017.04.002_bib0410","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2017.04.002_bib0415","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/15412555.2013.831061","article-title":"Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma","volume":"11","author":"Rhee","year":"2014","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2017.04.002_bib0420","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/thx.2007.089193","article-title":"Proportional classifications of COPD phenotypes","volume":"63","author":"Marsh","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2017.04.002_bib0425","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.124.2.474","article-title":"The proportional Venn diagram of obstructive lung disease","volume":"124","author":"Soriano","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2017.04.002_bib0430","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12955-014-0120-5","article-title":"Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems","volume":"12","author":"Miravitlles","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.arbres.2017.04.002_bib0435","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.arbres.2013.12.013","article-title":"Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke","volume":"50","author":"Golpe","year":"2014","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2017.04.002_bib0440","doi-asserted-by":"crossref","first-page":"15047","DOI":"10.1038\/npjpcrm.2015.47","article-title":"Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: A cross-sectional study","volume":"25","author":"Kiljander","year":"2015","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.arbres.2017.04.002_bib0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/ecp.13.2","article-title":"The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations","volume":"6","author":"Louie","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.arbres.2017.04.002_bib0450","doi-asserted-by":"crossref","first-page":"1601446","DOI":"10.1183\/13993003.01446-2016","article-title":"Phenotypes of COPD patients with a smoking history in Central and Eastern Europe\u2014the POPE Study","volume":"49","author":"Koblizek","year":"2017","journal-title":"Eur Respir J"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289617300923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289617300923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T02:21:50Z","timestamp":1535854910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289617300923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0300289617300923"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2017.04.002","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Gu\u00eda espa\u00f1ola de la EPOC (GesEPOC) y la Gu\u00eda Espa\u00f1ola para el Manejo del Asma (GEMA)","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}